This content is protected against AI scraping.
National Organization for the Reform of Marijuana Laws (NORML) is asking to take part in a federal hearing about whether cannabis should be moved from the most restricted drug category (Schedule I) to Schedule III. The organization agrees marijuana should not stay in Schedule I, but says Schedule III still treats cannabis only as a medical product and does not fully recognize the millions of adults who legally use cannabis under state laws.
NORML believes cannabis should eventually be completely removed from the federal controlled substances list and regulated more like alcohol or tobacco, with rules focused on safety, testing, labeling, and keeping products away from minors. The group argues that adult cannabis users should not have to be considered “patients” just because federal law has no better category for them.
The upcoming hearing, set for June 29, 2026, will help determine how cannabis is classified under federal law. NORML says it wants to represent everyday cannabis consumers during the process because current federal rules still leave many legal state users vulnerable to federal penalties, even in states where cannabis is allowed.
This is a summary.
Read the original article: NORML Seeks Seat at DEA Marijuana Rescheduling Hearing, Says Consumers Must Be Represented
Original article written and published by NORML on May 26, 2026.
